Creating a transdisciplinary research center to reduce cardiovascular health disparities in Baltimore, Maryland:

Lisa A Cooper1, L Ebony Boulware, Edgar R Miller

  • 1Lisa A. Cooper, L. Ebony Boulware, Edgar R. Miller III, Sherita Hill Golden, Gary Noronha, Hsin-Chieh Yeh, David M. Levine, Felicia Hill-Briggs, Jeanne Charleston, Nae-Yuh Wang, Hanan Aboumatar, Jennifer P. Halbert, and Frederick L. Brancati are with the Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD. Kathryn A. Carson and Patti L. Ephraim are with the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore. Mary Margaret Huizinga is with Vanderbilt University School of Medicine in Nashville, TN. Debra L. Roter and Lee R. Bone are with the Department of Health Behavior and Society at the Johns Hopkins Bloomberg School of Public Health. Miyong Kim is with the Johns Hopkins University School of Nursing, Baltimore.

Insights

Cardiovascular disease disparities negatively impact African Americans due to uncontrolled hypertension. A new center in Baltimore aims to reduce these disparities by targeting multiple influence levels and fostering community partnerships.

Area of Science:

  • Public Health
  • Cardiovascular Health
  • Health Disparities Research

Background:

  • Cardiovascular disease (CVD) disparities persist among African Americans in the U.S., primarily driven by uncontrolled hypertension.
  • Evidence-based interventions for hypertension management are underutilized in clinical and public health practices, hindering progress in reducing CVD disparities.

Purpose of the Study:

  • To establish the Johns Hopkins Center to Eliminate Cardiovascular Health Disparities, a transdisciplinary research program focused on reducing CVD disparities in vulnerable populations.
  • To address the core problem of health disparities in Baltimore by targeting multiple levels of influence.
  • To support three research studies and train future CVD researchers.

Main Methods:

  • Implementing a transdisciplinary research program with a novel structure.
  • Leveraging academic, community, and national partnerships.
  • Targeting multiple levels of influence to address health disparities.

Main Results:

  • The establishment of a new center dedicated to eliminating cardiovascular health disparities.
  • Initiation of three research studies focused on CVD disparities in Baltimore.
  • Development of a framework for training the next generation of CVD researchers.

Conclusions:

  • The center's multi-level approach and collaborative partnerships are crucial for tackling complex health disparities.
  • Early lessons learned from the center's design provide valuable insights for future initiatives.
  • A concerted effort is needed to translate evidence-based interventions into practice to reduce CVD disparities.

Related Concept Videos

Longitudinal Studies01:26

Longitudinal Studies

Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...